International Journal of Pharmaceutical Compounding

A subscription to IJPC provides on-line access to full-text, full-color, printable PDF copies of all issues and individual articles published by the Journal since 1997.

LEARN MORE

Carvedilol 1.25-mg/mL Oral Suspension

Author(s): Allen Loyd V Jr

Issue: May/Jun 2006 - Hormone Replacement Therapy
View All Articles in Issue

Page(s): 220

Carvedilol 1.25-mg/mL Oral Suspension Page 1

Download in electronic PDF format for $75

Abstract: A formulation for preparing Carvedilol 1.25-mg/mL Oral Suspension. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.

Related Keywords: carvedilol, nonselective beta adrenergic blocking agent, nonselective beta blocker, hypertension, high blood pressure, congestive heart failure, heart disease, cardiovascular disorders, antihypertensive agent

Related Categories: FORMULATIONS, CARDIOLOGY, NEUROLOGY

Printer-Friendly Version

Title/Author (Click for Abstract / Details / Purchase)	Issue/Page View/Buy
Related Articles from IJPC
Carvedilol 1.25-mg/mL Oral Suspension Allen Loyd V Jr	May/Jun 2006 Pg. 220
Carvedilol 0.625-mg/mL Oral Liquid Allen Loyd V Jr	Sep/Oct 2011 Pg. 418
Carvedilol 3.125-mg, 6.25-mg, 12.5 mg, or 25-mg capsules Allen Loyd V Jr	Mar/Apr 2016 Pg. 145
Carvedilol 1-mg/mL Oral Suspension Allen Loyd V Jr	Sep/Oct 2010 Pg. 423
Coenzyme Q10 Supplementation in the Treatment of Heart Disease Bramwell Bethany L	Mar/Apr 2010 Pg. 108-111
Congestive Heart Failure and Other Medical Facts About Ferrets; Scout's Story: A Case Report on Treating Congestive Heart Failure in a Ferret Williams LaVonn A, Riley Kari	Sep/Oct 2009 Pg. 367-371
A Compendium of Compounding Agents and Formulations, Part 5: Timolol and Beta-glucans Riepl Mike	Sep/Oct 2022 Pg. 364-368
Compounded Beta-blocker Nasal Spray for Treatment of Acute Migraine: A New Therapeutic Modality Hagan John C III, Everett Eric, Chamberlain Tyler	May/Jun 2020 Pg. 194-197
Metoprolol Tartrate 10 mg/mL in SyrSpend SF pH4 Oral Suspension Allen Loyd V Jr	Nov/Dec 2021 Pg. 503
Compounding in the Pharmacy Curriculum: Beyond the Basics Hinkle Amanda R, Newton Gail D	May/Jun 2004 Pg. 181-185
Metoprolol Tartrate 1.25-mg/mL Oral Liquid Allen Loyd V Jr	Sep/Oct 2011 Pg. 421
Metoprolol Tartrate 1-mg/mL Injection Allen Loyd V Jr	Jul/Aug 2013 Pg. 333
Combating Cardiovascular Disease With Compounded Medications. Part 1: Combination Cardiac Medicines to Control Blood Pressure Harrington Catherine A, Cauffield Jacintha	Mar/Apr 2005 Pg. 117-119
Stability of Propranolol Hydrochloride in SyrSpend SF Geiger Christine M, Voudrie Mark A II, Sorenson Bridget	Nov/Dec 2012 Pg. 513-515
Propranolol Hydrochloride 1-mg/mL Injection Allen Loyd V Jr	Jul/Aug 2014 Pg. 330
Quinapril 1-mg/mL Oral Liquid Allen Loyd V Jr	May/Jun 2006 Pg. 227
Combating Cardiovascular Disease with Compounded Medications -- Part 2: Clinical and Compounding Issues for Antihypertensive Drugs Harrington Catherine A, Cauffield Jacintha	May/Jun 2005 Pg. 201-205
Propranolol 2 mg/mL or 5 mg/mL in Ora-Sweet Allen Loyd V Jr	Nov/Dec 2021 Pg. 504
Propranolol 2 mg/mL and 5 mg/mL in Ora-Blend SF Suspension Allen Loyd V Jr	Mar/Apr 2022 Pg. 148
Spironolactone 5 mg/mL in SuspendIt Oral Suspension Allen Loyd V Jr	Nov/Dec 2017 Pg. 496
Return to Top